Leptin to Treat Lipodystrophy

NCT00025883 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

NIH

Sponsor class

Conditions

Lipodystrophy

Interventions

DRUG: Metreleptin

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)